Target intelligence / Profile preview

Nutrient transporters and metabolic pathways

Molecular classification
Transporter, Enzyme, Other
01

Overview

Nutrient transporters and metabolic pathways represent a broad class of biological systems responsible for the acquisition and utilization of essential molecules such as glucose, amino acids, and lipids (Source: Pavlova & Thompson, 2016, Cell Metabolism). These systems include the Solute Carrier (SLC) family of transporters, which facilitate the movement of solutes across biological membranes, and intracellular enzymatic cascades like glycolysis and the pentose phosphate pathway (Source: Lin et al., 2015, Nature Reviews Drug Discovery). In many diseases, particularly cancer, these pathways are reprogrammed to support rapid proliferation and survival, a phenomenon known as metabolic rewiring (Source: Hanahan & Weinberg, 2011, Cell). Therapeutic strategies often focus on inhibiting specific transporters, such as SGLT2 in diabetes or LAT1 in oncology, or targeting rate-limiting enzymes like dihydrofolate reductase (Source: PubMed). However, because these pathways are fundamental to normal physiological function, achieving therapeutic selectivity remains a significant challenge, often leading to concerns regarding systemic toxicity and metabolic homeostasis (Source: StatPearls).

Other names
Metabolic networksNutrient uptake systemsSolute carrier (SLC) mediated transportCellular metabolism
02

Mechanism of action

Inhibition of substrate transport across cellular membranes (e.g., SGLT2 inhibition) and competitive or non-competitive inhibition of metabolic enzymes (e.g., DHFR inhibition) to disrupt cellular energy production or biosynthesis (Source: Nature Reviews Drug Discovery, 2015).

03

Biological functions

MetabolismNutrient transportEnergy homeostasisCell growthSignal transduction
04

Disease associations

CancerDiabetes mellitusMetabolic syndromeInborn errors of metabolismNeurodegenerative disease
05

Safety considerations

Systemic metabolic disruptionHypoglycemiaLactic acidosisNutrient deficienciesOff-target effects on healthy tissue metabolism
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Blood glucose levelsHbA1cLactate levels18F-FDG PET imaging uptake

Beyond the preview

Go deeper on Nutrient transporters and metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrient transporters and metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call